NKF Spring Clinical Meetings 2019

Access to Care for Hemodialysis Patients During Natural Disasters

Boston—Among patients dependent on renal replacement therapy, the effects of missed treatments are severe, making access to care for in-center hemodialysis patients critical during and after a natural disaster. Stephanie Baterseh (United Kingdom) and Vijay Lapsia, MD, (United States) conducted a review of existing literature to examine the state of the art in managing care of dialysis patients in the ... Read More »

Awareness of Proteinuria in the Community Setting: KDSAP Results

Boston—The Kidney Disease Screening and Awareness Program (KDSAP), working to increase early detection and improve awareness of kidney disease, provides free screening and education in the community setting. Proteinuria is an independent predictor of adverse clinical outcomes, yet due to the asymptomatic nature of proteinuria, early recognition is difficult; most individuals with proteinuria are not aware they have this condition. ... Read More »

AKI Incidence in Patients Undergoing Total Hip Arthroplasty

Boston—Worldwide, the number of total hip arthroplasties being performed is increasing rapidly. Sohail Abdul Salim, MD, and colleagues recently conducted a literature search and meta-analysis to examine the incidence of acute kidney injury (AKI) in patients undergoing the procedure. They reported results of the meta-analysis during a poster session at the NKF Spring Clinical Meetings in a poster titled Incidence ... Read More »

Late-Breaker: Primary Results of AMBER: Patiromer plus Spironolactone for Blood Pressure Management

Boston—Treatment-resistant hypertension is a common complication of chronic kidney disease (CKD), yet the use of renin-angiotensin-aldostyerone system inhibitor (RAASi) drugs may be limited in patients with CKD due to hyperkalemia. The PATHWAY-2 trial demonstrated that spironolactone was an effective fourth-line therapy for treatment-resistant hypertension; however, patients with advanced CKD were excluded from that trial. The phase 2 AMBER study was ... Read More »

Cost-Effectiveness of Treatments for Anemia in CKD

Boston—For patients with chronic kidney disease (CKD) with anemia, clinical guidelines recommend erythropoietin-stimulating agents (ESA), oral or intravenous (IV) iron, or red blood cell transfusions. The treatment recommendations depend on hemoglobin level and prior treatment. The economic implications of the treatment decisions are uncertain. Tara Lavelle, PhD, and colleagues recently conducted a review of published cost-effective analyses to improve understanding ... Read More »

Association of Gestational Diabetes and CKD by Race/Ethnicity

Boston—Diabetes is a leading cause of chronic kidney disease (CKD). Women who develop gestational diabetes are at increased risk for diabetes and thus for CKD. Non-white women are at increased risk for diabetes, albuminuria, and progression of CKD compared with non-Hispanic white women. Joanne Rodrigue, MPH, and colleagues conducted an analysis to examine the link between gestational diabetes and CKD ... Read More »

Changes in Kidney Function in Elderly Patients with and without Nephrology Referral

Boston—With increases in life expectancy, there are more geriatric patients being referred to nephrology for management of chronic kidney disease (CKD). It is uncertain whether referral of geriatric patients improves outcomes; one recent study did not show any benefit of trending change in estimated glomerular filtration rate (eGFR) as a predictor of mortality in elderly patients; results of a study ... Read More »

Patient Perceptions of Their Experience at Dialysis Center

Boston—An understanding of the factors that drive dialysis patients’ experiences is crucial in providing care. It is unclear whether the In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH-CAHPS) survey reflects themes that contemporary hemodialysis patients have identified as important. Kathryn S. Gray, MS, and colleagues at DaVita Clinical Research, Minneapolis, Minnesota, distributed an anonymous paper survey at 29 ... Read More »

Vitality Scores among Peritoneal Dialysis Patients Differ Between Countries

Boston—There are few data available regarding fatigue in patients with end-stage renal disease treated with peritoneal dialysis. The 36-Item Short Form Health Survey (SF-36) vitality scale has been used to establish hemodialysis patients’ perception of energy/fatigue; however, only a few small populations of peritoneal dialysis patients have been profiled using the scale. It is also unknown whether variations exist in ... Read More »

Management of Hyperkalemia with Patiromer in Real-World Setting

Boston—Csaba P. Kovesdy, MD, and colleagues recently conducted a retrospective cohort study to examine the incidence of hyperkalemia following initiation of patiromer in patients with hyperkalemia on chronic hemodialysis. Results of the study were reported at the NKF Spring Clinical Meetings in a poster titled Real-World Evaluation of Potassium Levels in Hemodialysis Patients Initiating Treatment with Patiromer. Patiromer is a ... Read More »